HEALTH NUCLEUS
DEAD

Serial Number

86859702

Owner

HLI Nucleus Holdings, LLC

Attorney

Anna King

First Use Date

Aug 31, 2015

Filing Date

Dec 28, 2015

Add to watchlist:

No watchlists yet
View on USPTO

HEALTH NUCLEUS Trademark

Serial Number: 86859702 • Registration: 5974699

HEALTH NUCLEUS is a trademark filed by HLI Nucleus Holdings, LLC on December 28, 2015. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

HLI Nucleus Holdings, LLC

SAN DIEGO, CA 92121

Entity Type: 16

Trademark Details

Filing Date

December 28, 2015

Registration Date

February 4, 2020

First Use Anywhere

August 31, 2015

First Use in Commerce

October 12, 2015

Published for Opposition

November 19, 2019

Cancellation Date

August 14, 2026

Goods & Services

scientific research services in the field of genomics and advanced clinical imaging to be used for personalized health; research and development in the field of genome sequencing and genome analysis; providing scientific analysis of aggregated results comprised primarily of genomic and microbiome sequencing, genomic and microbiome analysis, genetic testing and screening for research purposes, metabolomics data, phenotyping data, molecular analytics, patient scientific and medical information, genealogical information, health risk assessment, and preparing related information reports therefor; providing scientific analysis of aggregated results comprised primarily of genomic and microbiome sequencing, genomic and microbiome analysis, genetic testing and screening for research purposes, metabolomics data, phenotyping data, molecular analytics, patient scientific and medical information, genealogical information, health risk assessment from information obtained through advanced clinical imaging, namely, ultrasound imaging, magnetic resonance imaging (MRI), X-ray, radiography, computed tomography (CT), fluoroscopy, positron emission tomography, mammography, and echocardiogram services, and preparing related information reports therefor; providing online searchable databases in the fields of genomic and microbiome sequencing, genomic and microbiome analysis, genetic testing and screening for research purposes, metabolomics data, phenotyping, molecular analytics, patient scientific and medical information, genealogical information, advanced clinical imaging, health risk assessment for scientific research purposes; application service provider (ASP) featuring software for use in data management, data storage, data analysis, report generation, all in the fields of genomic and microbiome sequencing, genomic and microbiome analysis, genetic testing and screening for research purposes, and health risk assessment; scientific research in the fields of genomics, genetics, genetic testing, genetic screening, genotyping, phenotyping, molecular analytics, health risk assessment, and genealogical information; scientific research in the fields of genomics, genetics, genetic testing, genetic screening, genotyping, phenotyping, molecular analytics, health risk assessment from information obtained through advanced clinical imaging, namely, ultrasound imaging, magnetic resonance imaging (MRI), X-ray, radiography, computed tomography (CT), fluoroscopy, positron emission tomography, mammography, and echocardiogram services, and genealogical information; medical research; scientific investigations for medical purposes; medical and scientific research in the field of medical imaging; compiling data for research purposes in the field of medical science and medical consultancy; medical and scientific research in the field of genome sequence analysis and genome sequence reporting for research purposes, microbiome sequencing, metabolome analysis, advanced clinical imaging, laboratory tests, health risk assessment, medical imaging and DNA screening; research and development in the field of genome sequence analysis and genome sequence reporting, microbiome sequencing, metabolome analysis, advanced clinical imaging, laboratory tests, health risk assessment, medical imaging and DNA screening; scientific research for medical purposes in the field of genome sequence analysis and genome sequence reporting, microbiome sequencing, metabolome analysis, advanced clinical imaging, laboratory tests, health risk assessment, medical imaging and DNA screening; genetic testing of humans for scientific research purposes; all for scientific research purposes

genetic testing of humans for medical diagnostic purposes; consulting services in the fields of diagnostic medical testing; DNA screening for medical purposes; genetic counseling; medical assistance consultancy provided by doctors and other specialized medical personnel; medical assistance consultancy provided by genomics and genetics experts; medical assistance services in the nature of genetic and medical information provided to medical professionals from remote locations via the internet and global computer networks through the use of archived genome sequence information, medical images, diagnostic test results, and a data storage and retrieval system; medical genetic testing consultations provided via phone, online chat or videoconferencing; medical diagnostic testing, monitoring and reporting services; medical imaging services; medical information; medical screening; medical testing for diagnostic purposes; medical testing of blood, saliva, stool; multi-disciplinary, integrative, genetic consultations for medical treatment purposes; providing a web site featuring genetic and medical information; providing an internet website for medical professionals and medical patients featuring medical information from remote locations via devices that feed information to the website that is processed, exchanged and accessed in real-time by users; providing an internet website for medical professionals and medical patients featuring medical information from remote locations via electronic patient monitoring devices that feed information to the web site that can be accessed in real-time by medical professionals for purposes of monitoring and diagnosing medical conditions; providing medical information; providing medical information, consultancy and advisory services; providing medical profiles and medical record analysis and assessments via a website that are designed to provide custom tailored outputs about recommended resources and treatments associated with a defined set of symptoms, concerns, genome sequencing analysis, microbiome sequencing analysis, metabolome analysis, advanced clinical imaging, laboratory tests, and medical imaging and DNA screening; providing medical testing and medical consultations to individuals and their physicians to help them make health, wellness and nutritional changes in their daily living to improve health; providing on-line medical record analysis services designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms based on genome sequencing analysis, microbiome sequencing analysis, metabolome analysis, advanced clinical imaging, laboratory tests, and medical imaging and DNA screening; provision of health care and medical services by health care professionals via the internet or telecommunication networks; remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes; health assessment services, namely, providing assessment of risk of disease and providing health monitoring of individuals all through use of genome sequencing analysis and reporting, microbiome sequencing analysis, metabolome analysis, advanced clinical imaging, laboratory tests, and medical imaging and DNA screening; all for medical treatment and diagnostic purposes

Filing History

CANCELLED SEC. 8 (6-YR)
Aug 14, 2026 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 4, 2025 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 18, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 18, 2023 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Apr 18, 2023 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 18, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 18, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 18, 2023 COAR
REGISTERED-PRINCIPAL REGISTER
Feb 4, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 19, 2019 NPUB
PUBLISHED FOR OPPOSITION
Nov 19, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 30, 2019 NONP
EXPARTE APPEAL TERMINATED
Oct 10, 2019 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 10, 2019 CNSA
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Oct 3, 2019 JURT
REPLY BRIEF FILED - CHECK TTAB FILES
Sep 4, 2019 RBFT
NOTIFICATION OF EXAMINERS STATEMENT E-MAILED
Aug 13, 2019 GNSN
EXAMINERS STATEMENT E-MAILED
Aug 13, 2019 GNES
EXAMINERS STATEMENT - COMPLETED
Aug 13, 2019 CNES
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jul 23, 2019 JURT
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Jul 18, 2019 GEA1
ACTION DENYING REQ FOR RECON E-MAILED
Jul 18, 2019 GECD
ACTION CONTINUING FINAL - COMPLETED
Jul 18, 2019 CNCF
ASSIGNED TO EXAMINER
Jun 20, 2019 DOCK
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jun 12, 2019 JURT
EX PARTE APPEAL-INSTITUTED
Jun 12, 2018 EXPI
EXPARTE APPEAL RECEIVED AT TTAB
Jun 12, 2018 EXAF
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 13, 2017 GNFN
FINAL REFUSAL E-MAILED
Dec 13, 2017 GNFR
FINAL REFUSAL WRITTEN
Dec 13, 2017 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 21, 2017 TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 21, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 21, 2017 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 20, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 20, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 19, 2017 GNRN
NON-FINAL ACTION E-MAILED
May 19, 2017 GNRT
NON-FINAL ACTION WRITTEN
May 19, 2017 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 9, 2017 RCCK
ASSIGNED TO LIE
May 9, 2017 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 1, 2016 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 1, 2016 GNSL
SUSPENSION LETTER WRITTEN
Nov 1, 2016 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 19, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 19, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 19, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 19, 2016 GNRN
NON-FINAL ACTION E-MAILED
Apr 19, 2016 GNRT
NON-FINAL ACTION WRITTEN
Apr 19, 2016 CNRT
ASSIGNED TO EXAMINER
Apr 12, 2016 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jan 8, 2016 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 7, 2016 NWOS
NEW APPLICATION ENTERED
Dec 31, 2015 NWAP